Mediwound Stock Market Value
MDWD Stock | USD 17.33 0.85 5.16% |
Symbol | Mediwound |
Mediwound Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 2.18 | Quarterly Revenue Growth 0.061 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mediwound 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mediwound's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mediwound.
07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Mediwound on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Mediwound or generate 0.0% return on investment in Mediwound over 510 days. Mediwound is related to or competes with Capricor Therapeutics, Soleno Therapeutics, Bio Path, Moleculin Biotech, Crinetics Pharmaceuticals, Assembly Biosciences, and Instil Bio. MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic soluti... More
Mediwound Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mediwound's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mediwound upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.06) | |||
Maximum Drawdown | 17.42 | |||
Value At Risk | (5.18) | |||
Potential Upside | 5.21 |
Mediwound Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mediwound's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mediwound's standard deviation. In reality, there are many statistical measures that can use Mediwound historical prices to predict the future Mediwound's volatility.Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.23) | |||
Total Risk Alpha | (0.55) | |||
Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mediwound's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mediwound Backtested Returns
Mediwound has Sharpe Ratio of -0.0406, which conveys that the firm had a -0.0406% return per unit of risk over the last 3 months. Mediwound exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mediwound's Risk Adjusted Performance of (0.01), mean deviation of 2.32, and Standard Deviation of 3.16 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.41, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mediwound will likely underperform. At this point, Mediwound has a negative expected return of -0.12%. Please make sure to verify Mediwound's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Mediwound performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.22 |
Weak reverse predictability
Mediwound has weak reverse predictability. Overlapping area represents the amount of predictability between Mediwound time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mediwound price movement. The serial correlation of -0.22 indicates that over 22.0% of current Mediwound price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.22 | |
Spearman Rank Test | -0.08 | |
Residual Average | 0.0 | |
Price Variance | 2.24 |
Mediwound lagged returns against current returns
Autocorrelation, which is Mediwound stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mediwound's stock expected returns. We can calculate the autocorrelation of Mediwound returns to help us make a trade decision. For example, suppose you find that Mediwound has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Mediwound regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mediwound stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mediwound stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mediwound stock over time.
Current vs Lagged Prices |
Timeline |
Mediwound Lagged Returns
When evaluating Mediwound's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mediwound stock have on its future price. Mediwound autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mediwound autocorrelation shows the relationship between Mediwound stock current value and its past values and can show if there is a momentum factor associated with investing in Mediwound.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:Check out Mediwound Correlation, Mediwound Volatility and Mediwound Alpha and Beta module to complement your research on Mediwound. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Mediwound technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.